<div id="container" class="bg4"> 
     <div class="title11 tradegothicltstd_bd2">
      <i18n id="v19_title11"></i18n>
    </div>
  <!--menu top-->
   <div id="menu_top"></div>
  <!--end menu top-->
  
  <div class="titleTL">
    <i18n id="v19_titlet06">Diagnostik
</i18n>
  </div>
  <!--end .titleTL--> 
  
  <!--elements-->
  <div class="btn_lib"></div>
  <div class="btn_ref"></div>
  <div class="btn_hand"></div>
  
  <!--end elements-->
  
  <div id="main_container">
    <div class="claim tradegothicltstd_bd2">
      <i18n id="v19_txt_claim_t06">Differentialdiagnose thombotischer Mikroangipopathien (TMA): aHUS, TTP  und STEC-HUS</i18n>
    </div>
    
    <!--bg_center1-->
    <div class="bg_center1"> 
      <!--text red-->
      <div class="text_red_top_left">
        <i18n id="v19_txt_red_01">Thrombozytopenie<sup>(6,27,35)</sup></i18n>
      </div>
      <div class="text_red_top_right">
        <i18n id="v19_txt_red_02">Mikroangiopathische hämolytische Anämie<sup>(6,16,35)</sup></i18n>
      </div>
      <!--End text red--> 
      <!--text content-->
      <div class="text_content_top_left">
        <i18n id="v19_txt_content_01">Thrombozytenzahl < 150 000/µl<sup>(6,27,35)</sup> oder >25% Abnahme<br>
          zum Ausgangswert<sup>(37)</sup></i18n>
      </div>
      <div class="text_content_top_right">
        <i18n id="v19_txt_content_02">Schistozyten<sup>(6,16,35)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_02_01">und/oder</i18n>
        </span>
        <i18n id="v19_txt_content_02_02">erhöhte LDH<sup>(6,35)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_02_03">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_02_04">verringertes Haptoglobin<sup>(6,35)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_02_05">und/oder</i18n>
        </span>
        <i18n id="v19_txt_content_02_06">verringertes Hämoglobin<sup>(6)</sup></i18n>
      </div>
      <div class="text_and">
        <i18n id="v19_txt_and">UND</i18n>
      </div>
      <div class="text_plus">
        <i18n id="v19_txt_plus">plus ein oder mehrere<br>
         der folgenden Punkte:</i18n>
      </div>
      <!--text leg--> 
      
      <!--End content--> 
    </div>
    <!--end bg_center1--> 
    
    <!--bg_center2-->
    <div class="bg_center2"> 
      <!--text red-->
      <div class="text_red_bottom_left">
        <i18n id="v19_txt_red_03">Neurologische Symptome<sup>(7,20,22,23)</sup></i18n>
      </div>
      <div class="text_red_bottom_center">
        <i18n id="v19_txt_red_04">Niereninsuffizienz<sup>(6,18,39)</sup></i18n>
      </div>
      <div class="text_red_bottom_right">
        <i18n id="v19_txt_red_05">Gastrointestinale Symptome<sup>(1,6,23)</sup></i18n>
      </div>
      <!--End text red--> 
      <!--text content-->
      <div class="text_content_bottom_left">
        <i18n id="v19_txt_content_03">Verwirrtheit<sup>(20)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_03_01">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_03_02">Krampfanfälle<sup>(7,23)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_03_03">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_03_04">Zerebrale Veränderungen<sup>(20,22)</sup></i18n>
      </div>
      <div class="text_content_bottom_center">
        <i18n id="v19_txt_content_04">erhöhtes Kreatinin<sup>(18)</sup> </i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_04_01">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_04_02">erniedrigte eGFR<sup>(38)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_04_03">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_04_04">erhöhter Blutdruck<sup>(40)</sup> </i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_04_05">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_04_06">auffällige Urinanalyse<sup>(18,39)</sup></i18n>
      </div>
      <div class="text_content_bottom_right">
        <i18n id="v19_txt_content_05">Diarrhoe +/- Blut<sup>(1,26)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_05_01">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_05_02">Übelkeit/Erbrechen<sup>(23)</sup></i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_05_03">und/oder</i18n>
        </span><br>
        <i18n id="v19_txt_content_05_04">abdominale Schmerzen<sup>(23)</sup> </i18n>
        <span class="tradegothicltstd_obl">
        <i18n id="v19_txt_content_05_05">und/oder</i18n>
        </span>
        <i18n id="v19_txt_content_05_06">Gastroenteritis<sup>(1,6)</sup></i18n>
      </div>
      
      <!--End content--> 
    </div>
    <!--end bg_center2--> 
    <div class="bg_center3">
    	<div class=" center3_text1 tradegothic_re"><i18n id="v19_center3_text1">Nicht vergessen:<br>
            Blutprobe vor der ersten<br>
            Plasmaintervention abnehmen</i18n>
        </div>
        <div class=" center3_text2 tradegothic_re"><i18n id="v19_center3_text2">ADAMTS13-Aktivität/<br>
Shigatoxin/EHEC*-Test<sup>(26,32,35,36)</sup></i18n>
        </div>
    </div>
    <!--bg_center3-->
    <div class="bg_center4"> 
      <!--text content-->
      <div class="text_eval">
        <i18n id="v19_txt_eval">Bis zum Vorliegen des ADAMTS13-Befundes kann eine schwere ADAMTS13-Defizienz (TTP) nahezu ausgeschlossen
werden, wenn die Thrombozytenzahl > 30 000/µl oder das Serum-Kreatinin > 150-200µmol/l (1,7-2,3 mg/dl) ist.<sup>(45)</sup></i18n>
      </div>
      <div class="text_adam">
        <i18n id="v19_txt_adam"><5% ADAMTS13-Aktivität<sup>(35,36)</sup></i18n>
      </div>
      <div class="text_shiga">
        <i18n id="v19_txt_shiga">Shiga-toxin/EHEC Positiv<sup>(26,32)</sup></i18n>
      </div>
      <div class="text_act">
        <i18n id="v19_txt_act">≥5% ADAMTS13-Aktivität<sup>(35,36)</sup></i18n>
      </div>
      
      <!--End content--> 
    </div>
    <!--end bg_center3--> 
    
    <!--bg_center4-->
    <div class="bg_center5"> 
      <!--text content-->
      <div class="btn_ttp btn_active">
        <i18n id="v19_txt_ttp">TTP</i18n>
      </div>
      <div class="btn_ahus btn_active">
        <i18n id="v19_txt_ahus">aHUS</i18n>
      </div>
      <div class="btn_stec btn_active">
        <i18n id="v19_txt_stec">STEC-HUS*</i18n>
      </div>
      
      <!--End content--> 
    </div>
    <!--end bg_center4-->
    
    
  </div>
  <!--End #main_container -->
  
  <div class="claim_2line">
    <i18n id="v19_txt_nav_t06">Eine frühe aHUS-Diagnose ist entscheidend<sup>(6)</sup></small></i18n>
  </div>
  <!--end .claim_1line-->
  
  <div class="lg_alexion"></div>
  
  <!--Ref-->
  <div class="ref_warpper bg_ref">
    <h1>
      <i18n id="v19_refernces">REFERENZEN</i18n>
    </h1>
    <div class="inner_wapper">
      <div class="scroller">
       <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_002">1.</i18n>
          </span>
          <i18n id="v19_content_number_002">Noris M, Caprioli J, Bresin E et al. Clin J Am Soc Nephrol. 2010;5:1844-1859</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number ">
          <i18n id="v19_number_4">6.</i18n>
          </span>
          <i18n id="v19_content_number_4">Caprioli J, Noris M, Brioschi S, et al. International Registry of Recurrent and Familial HUS/TTP. Blood. 2006; 108: 1267-1279</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_000_05">7.</i18n>
          </span>
          <i18n id="v19_content_number_0005">Neuhaus TJ, Calonder S, Leumann EP. Arch Dis Child. 1997; 76: 518-521</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_03">16.</i18n>
          </span>
          <i18n id="v19_content_number_03">Noris M, Remuzzi G. N Engl J Med. 2009; 361: 1676-1687</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_04">18.</i18n>
          </span>
          <i18n id="v19_content_number_04">Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et al. French Society of Pediatric Nephrology. J Am Soc Nephrol. 2007; 18: 2392-2400</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_0_005">19.</i18n>
          </span>
          <i18n id="v19_content_number_0_05">Data on file. Alexion Pharmaceuticals, Inc</i18n>         
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_20">20.</i18n>
          </span>
          <i18n id="v19_content_number_20">Noris M et al. J Am Soc Nephrol. 2005;16:1177–1183</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_06">22.</i18n>
          </span>
          <i18n id="v19_content_number_06">Ohanian M, CableC, Halka K. Clin Pharmacol Adv Appl. 2011; 3: 5-12</i18n>
        </div>
        <!---end ref-->
         <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_013">23.</i18n>
          </span>
          <i18n id="v19_content_number_013">Dragon-Durey MA, Sethi SK, Bagga A et al. J Am Soc Nephrol. 2010;21:2180-2187</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_07">24.</i18n>
          </span>
          <i18n id="v19_content_number_07">Hirt-Minkowski P, Dickenmann M, Schifferli JA. Nephron Clin Pract. 2010; 114: c219-c235</i18n>         </div>
          <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_26">26.</i18n>
          </span>
          <i18n id="v19_content_number_26">Ariceta G, Besbas N, Johnson S et al. European Pædiatric Study Group for HUS. Pediatr. Nephrol. 2009;24:687-696</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_27">27.</i18n>
          </span>
          <i18n id="v19_content_number_27">Loirat C, Frémeaux-Bacchi V. Orphanet J Rare Dis. 2011;6:60</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_08">28.</i18n>
          </span>
          <i18n id="v19_content_number_08">Sadler JE, Moake JL, Miyata T, George JN. Hematology. Am Soc Hematol Educ Program. 2004: 407-423</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_10">29.</i18n>
          </span>
          <i18n id="v19_content_number_10">Moake JL. N Engl J Med. 2002; 347: 589-600</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_12">30.</i18n>
          </span>
          <i18n id="v19_content_number_12">Zheng XL. Blood. 2010; 115:1475-1476</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_13">31.</i18n>
          </span>
          <i18n id="v19_content_number_13">Ruggenenti P, Noris M, Remuzzi G. Kidney Int.2001;60:831-846</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_14">32.</i18n>
          </span>
          <i18n id="v19_content_number_14">Bitzan M, Schaefer F, Reymond D. Semin Thromb Hemost. 2010; 36: 594-610</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_15">33.</i18n>
          </span>
          <i18n id="v19_content_number_15">Mayer SA, Aledort LM. Mt Sinai J Med.2005; 72: 166-175</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_16">34.</i18n>
          </span>
          <i18n id="v19_content_number_16">Tsai HM. J Am Soc Nephrol. 2003; 14: 1072-1081</i18n>          
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_035">35.</i18n>
          </span>
          <i18n id="v19_content_number_035">Schubert J et al., (Eds) in Hämolytische Anämien. Unimed Verlag 2009;75–79</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_052">36.</i18n>
          </span>
          <i18n id="v19_content_number_052">Kremer Hovinga JA, J Thromb Haemost 2006;36:594–610</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_037">37.</i18n>
          </span>
          <i18n id="v19_content_number_037">Soliris<sup>&reg;</sup> (Eculizumab) Fachinformation Juni 2012 </i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_038">38.</i18n>
          </span>
          <i18n id="v19_content_number_038">Zimmerhackl B et al., Semin Thromb Hemost 2006;32:113–120</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_039">39.</i18n>
          </span>
          <i18n id="v19_content_number_039">Al-Akash SI, Almond PS, Savell VH Jr, Gharaybeh SI, Hogue C. Pediatr Nephro. 2011; 26: 613-619</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_040">40.</i18n>
          </span>
          <i18n id="v19_content_number_040">Garjau M et al.,Clin Kidney J 2012;5:31-33</i18n>
        </div>
        <!---end ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v19_num_045">45.</i18n>
          </span>
          <i18n id="v19_content_number_045">Zuber J et al., Nat Rev Nephrol. 2012 Nov;8(11):643-57. doi: 10.1038/nrneph.2012.214. Epub 2012</i18n>
        </div>
        <!---end ref-->
        <div class="ref">
          <i18n id="v19_content_number_17">TMA = Thrombotische Mikroangiopathie. <br>
            aHUS = atypisches Hämolytisch-Urämisches Syndrom. <br>
            TTP = Thrombotische thrombocytopenische Purpura. <br>
            STEC-HUS =Shigatoxin produzierende <i>E. coli</i> assoziiertes Hämolytisch-Urämisches Syndrom <br>
            LDH = Laktatdehydrogenase. <br>
            eGFR = Geschätzte Glomeruläre Filtrationsrate. <br>
            EHEC = Enterohämorrhagische <i>E. coli</i><br>
            *Shiga-toxin/EHEC-Diagnostik sinnvoll bei allen Patienten und obligat bei Anamnese/Vorliegen von gastrointestinalen Symptomen.</i18n>
        </div>
        
        <!--end Ref--> 
      </div>
      <!--end .scroller--> 
    </div>
    <!--end .inner_wapper-->
    <div class="close"></div>
  </div>
  <!--end ref--> 
  
</div>
<% 
slide.load('css/main.css',
		   'javascript/main.js'); 
%> 